ESR1 and breast carcinoma: We present a comprehensive liquid biopsy analysis of 13 ER(+) breast cancer patients initially diagnosed with operable disease, based on the analysis of serial peripheral blood samples at different time points in a period of ten years, and correlate our findings with the clinical outcome.